Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Symptom C0042749|viremia
Sentences 14
PubMedID- 20809700 They were classified according to viremia to patients with chronic hepatitis c with positive viremia and immune subjects with positive hcv igg alone.
PubMedID- 25535101 These studies demonstrated reductions in viremia, seroconversion of the hepatitis b “e” antigen (hbeag) to anti-hbe and hbv-specific t cell responses in some patients after vaccination.
PubMedID- 24976702 However during the course of infection precore and/or bcp variants may emerge and be selected leading to hbeag negative chronic hepatitis b (chb) with high viremia levels (reactivation phase).
PubMedID- 20735940 Additional information available for patients included hiv-1 viremia and co-infection with hepatitis b virus and hepatitis c virus.
PubMedID- 23794068 Four patients died with hev viremia, with signs of ongoing hepatitis, having a median time of infection of 4.1 months.
PubMedID- 23006491 a reasonable candidate for hcv therapy is an adult patient who is 18 years old or older, has hcv viremia, and displays evidence of chronic hepatitis with at least f2 fibrosis, or a well-compensated cirrhosis (total serum bilirubin < 25 μmol/l; inr < 1.5; serum albumin > 34 g/l, no hepatic encephalopathy or ascites).
PubMedID- 24658127 The main finding of the study was that the clinical significance of hdv viremia is different in patients with chronic hepatitis alone and in those with established cirrhosis.
PubMedID- 23202451 Initial hcv infection is most often followed by chronic hepatitis with persistence of viremia in up to 85% of individuals 2.
PubMedID- 23390496 The emergence of drug-resistant hbv results in breakthrough viremia leading to hepatitis and liver disease progression.
PubMedID- 23304475 A quantitative hcv core antigen (hcvcag) test has been developed for the confirmation of viremia in patients with hepatitis c. this test can detect total nucleocapsid core antigen whose sequence is highly conserved across hcv genotypes.
PubMedID- 25015956 Whereas the majority of hcv infections progress to chronic hepatitis with persistent viremia, at least 20% of patients spontaneously clear the infection.
PubMedID- 22177274 Background: a quantitative hcv core antigen (hcvcoreag) immunoassay has been developed for the confirmation of viremia in patients with hepatitis c.
PubMedID- 23922368 High ttv viremia is not associated with hepatitis after olt, but, conversely, liver inflammatory activity impairs ttv replication.
PubMedID- 26034549 The usefulness of anti-hcv signal to cut-off ratio in predicting viremia in anti-hcv in patients with hepatitis c virus infection.

Page: 1